Kirk Nielsen is a Managing Partner at Vensana Capital, a venture capital & growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare with breakthrough innovations in medical technology. Kirk co-founded Vensana in early 2019 as a Managing Director at Versant Ventures, where he led the firm’s medtech practice. He joined Versant in 2006 from Medtronic, where he worked in sales & marketing in the company’s Cardiac Rhythm Management division. Previously, he spent time at Fluidigm (a Versant portfolio company) and he also served as a consultant at Bain & Company, where he advised clients in healthcare, private equity, and other industries. Prior to his business career, Kirk was a professional hockey player. Kirk has led or co-led investments in numerous companies that have successfully exited, including Biotie Therapies, Cameron Health, CardiAQ, Ceterix Ortopedics, Inari Medical, Lutonix, NeuWave Medical, Sequent Medical, and Zyga Technology, and he remains active with Alleviant Medical, CVRx, Metavention, Monteris Medical, Nuvaira, Respicardia, and Veran Medical. Kirk also serves as a member of the Board of Directors of the National Venture Capital Association. Kirk graduated with a BA in Biology from Harvard College, where he won the John P. Reardon award as the school’s top scholar-athlete, and he earned an MBA from Harvard Business School, where he was a Baker Scholar.
What is Kirk G. Nielsen's net worth?
The estimated net worth of Kirk G. Nielsen is at least $24.76 million as of May 19th, 2022. Mr. Nielsen owns 1,685,466 shares of CVRx stock worth more than $24,759,496 as of April 23rd. This net worth estimate does not reflect any other assets that Mr. Nielsen may own. Learn More about Kirk G. Nielsen's net worth.
How do I contact Kirk G. Nielsen?
Has Kirk G. Nielsen been buying or selling shares of CVRx?
Kirk G. Nielsen has not been actively trading shares of CVRx during the last ninety days. Most recently, on Monday, May 23rd, Kirk G. Nielsen bought 4,432 shares of CVRx stock. The stock was acquired at an average cost of $5.04 per share, with a total value of $22,337.28. Following the completion of the transaction, the director now directly owns 1,703,285 shares of the company's stock, valued at $8,584,556.40. Learn More on Kirk G. Nielsen's trading history.
Who are CVRx's active insiders?
Are insiders buying or selling shares of CVRx?
During the last twelve months, insiders at the sold shares 4 times. They sold a total of 8,020 shares worth more than $183,176.38. The most recent insider tranaction occured on February, 20th when insider Paul Verrastro sold 2,545 shares worth more than $55,760.95. Insiders at CVRx own 18.3% of the company.
Learn More about insider trades at CVRx. Information on this page was last updated on 2/20/2024.
